Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 3/2019

01-09-2019 | Historical Perspectives in Pathology

Historical Evolution of the Polymorphous Adenocarcinoma

Author: Juan C. Hernandez-Prera

Published in: Head and Neck Pathology | Issue 3/2019

Login to get access

Abstract

The 2017 World Health Organization Classification of Head and Neck Tumors introduced for the first time the diagnostic terminology “cribriform variant of polymorphous adenocarcinoma”. This nomenclature attempts to reconciliate the ongoing taxonomical controversy related to cribriform adenocarcinoma of tongue. In order to better understand this classification conundrum, it is imperative for pathologist to comprehend the historical evolution of polymorphous adenocarcinoma formerly known as polymorphous “low grade” adenocarcinoma. This review highlights our understanding of these tumors since their origins.
Literature
1.
Freedman PD, Lumerman H. Lobular carcinoma of intraoral minor salivary gland origin. Report of twelve cases. Oral Surg Oral Med Oral Pathol. 1983;56(2):157–66.CrossRef
2.
Batsakis JG, Pinkston GR, Luna MA, Byers RM, Sciubba JJ, Tillery GW. Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol. 1983;97(9):825–35.CrossRef
3.
Chaudhry AP, Vickers RA, Gorlin RJ. Intraoral minor salivary gland tumors. An analysis of 1414 cases. Oral Surg Oral Med Oral Pathol. 1961;14:1194–226.CrossRef
4.
Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer 1984;53(4):935–42.CrossRef
5.
Mitchell DA, Eveson JW, Ord RA. Polymorphous low-grade adenocarcinoma of minor salivary glands—a report of three cases. Br J Oral Maxillofac Surg. 1989;27(6):494–500.CrossRef
6.
Wenig BM, Harpaz N, DelBridge C. Polymorphous low-grade adenocarcinoma of seromucous glands of the nasopharynx. A report of a case and a discussion of the morphologic and immunohistochemical features. Am J Clin Pathol. 1989;92(1):104–9.CrossRef
7.
Regezi JA, Zarbo RJ, Stewart JC, Courtney RM. Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol. 1991;71(4):469–75.CrossRef
8.
Nicolatou O, Kakarantza-Angelopoulou E, Angelopoulos AP, Anagnostopoulou S. Polymorphous low-grade adenocarcinoma of the palate: report of a case with electron microscopy. J Maxillofac Surg. 1988;46(11):1008–13.CrossRef
9.
Gnepp DR, Chen JC, Warren C. Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study. Am J Pathol. 1988;12(6):461–8.CrossRef
10.
Anderson C, Krutchkoff D, Pedersen C, Cartun R, Berman M. Polymorphous low grade adenocarcinoma of minor salivary gland: a clinicopathologic and comparative immunohistochemical study. Mod Pathol. 1990;3(1):76–82.PubMed
11.
Dardick I, van Nostrand AW. Polymorphous low-grade adenocarcinoma: a case report with ultrastructural findings. Oral Surg Oral Med Oral Pathol. 1988;66(4):459–65.CrossRef
12.
Simpson RH, Clarke TJ, Sarsfield PT, Gluckman PG, Babajews AV. Polymorphous low-grade adenocarcinoma of the salivary glands: a clinicopathological comparison with adenoid cystic carcinoma. Histopathology 1991;19(2):121–9.CrossRef
13.
Frierson HF Jr, Mills SE, Garland TA. Terminal duct carcinoma of minor salivary glands. A nonpapillary subtype of polymorphous low-grade adenocarcinoma. Am J Clin Pathol. 1985;84(1):8–14.CrossRef
14.
Aberle AM, Abrams AM, Bowe R, Melrose RJ, Handlers JP. Lobular (polymorphous low-grade) carcinoma of minor salivary glands. A clinicopathologic study of twenty cases. Oral Surg Oral Med Oral Pathol. 1985;60(4):387–95.CrossRef
15.
Waldron CA, el-Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol. 1988;66(3):323–33.CrossRef
16.
Seifert G, Brocheriou C, Cardesa A, Eveson JW. WHO international histological classification of tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract. 1990;186(5):555–81.CrossRef
17.
Seifert G. Histological classification of salivary gland tumours. Histological typing of salivary gland tumours. Berlin: Springer; 1991. pp. 9–10.CrossRef
18.
Allen MS Jr, Fitz-Hugh GS, Marsh WL Jr. Low-grade papillary adenocarcinoma of the palate. Cancer 1974;33(1):153–8.CrossRef
19.
Mills SE, Garland TA, Allen MS Jr. Low-grade papillary adenocarcinoma of palatal salivary gland origin. Am J Surg Pathol. 1984;8(5):367–74.CrossRef
20.
Slootweg PJ, Muller H. Low-grade adenocarcinoma of the oral cavity. A comparison between the terminal duct and the papillary type. J Cranio-Maxillofac Surg. 1987;15(6):359–64.CrossRef
21.
Batsakis JG, El-Naggar AK. Terminal duct adenocarcinomas of salivary tissues. Ann Otol Rhinol Laryngol. 1991;100(3):251–3.CrossRef
22.
Wenig BM, Gnepp DR. Polymorphous low-grade adenocarcinoma of minor salivary glands. In: Ellis GL, Auclair PL, Gnepp DR, editors. Surgical pathology of the salivary glands major problems in pathology. vol 25. Philadelphia: W. B. Saunders Company; 1991. pp. 409–10.
23.
Slootweg PJ. Low-grade adenocarcinoma of the oral cavity: polymorphous or papillary? J Oral Pathol Med. 1993;22(7):327–30.CrossRef
24.
Colmenero CM, Patron M, Burgueno M, Sierra I. Polymorphous low-grade adenocarcinoma of the oral cavity: a report of 14 cases. J Oral Maxillofac Surg. 1992;50(6):595–600.CrossRef
25.
Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol. 2000;24(10):1319–28.CrossRef
26.
Hunter JB, Smith RV, Brandwein-Gensler M. Low-grade papillary adenocarcinoma of the palate: the significance of distinguishing it from polymorphous low-grade adenocarcinoma. Head Neck Pathol. 2008;2(4):316–23.CrossRef
27.
Michal M, Skalova A, Simpson RH, Raslan WF, Curik R, Leivo I, et al. Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology 1999;35(6):495–501.CrossRef
28.
Perez-Ordonez B, Linkov I, Huvos AG. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation. Histopathology 1998;32(6):521–9.CrossRef
29.
Yajima M, Yamazaki T, Minemura T, Kotani A. Tubular adenocarcinoma of the apex of the tongue. J Oral Maxillofac Surg. 1989;47(1):86–8.CrossRef
30.
Crocker TP, Kreutner A Jr, Othersen HB Jr, Garvin AJ. Papillary adenocarcinoma of minor salivary gland origin in a child. Arch Otolaryngol. 1983;109(12):827–31.CrossRef
31.
Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer 1999;86(2):207–19.CrossRef
32.
Simpson RH, Pereira EM, Ribeiro AC, Abdulkadir A, Reis-Filho JS. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology 2002;41(3):250–9.CrossRef
33.
Luna MA, Wenig BM. Polymorphous low-grade adenocarcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. World health organization classification of tumours pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. pp. 223–4.
34.
Prasad KC, Kaniyur V, Pai RR, Nesari SS. Pedunculated cribriform adenocarcinoma of the base of the tongue. ENT J 2004;83(1):62–64.
35.
Čoček A, Hronková K, Voldánová J, Šach J, Skálová A, Ambruš M, et al. Cribriform adenocarcinoma of the base of the tongue and low-grade, polymorphic adenocarcinomas of the salivary glands. Oncol Lett. 2011;2(1):135–8.CrossRef
36.
Skalova A, Sima R, Kaspirkova-Nemcova J, Simpson RH, Elmberger G, Leivo I, et al. Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol. 2011;35(8):1168–76.CrossRef
37.
Borowski-Borowy P, Dyduch G, Papla B, Gabryś I, Składzień J, Okoń K. Cribriform adenocarcinoma of the tongue. Pol J Pathol. 2011;62(3):198–71.
38.
Laco J, Kamarádová K, Vítková P, Sehnálková E, Dvořáková Š, Václavíková E, et al. Cribriform adenocarcinoma of minor salivary glands may express galectin-3, cytokeratin 19, and HBME-1 and contains polymorphisms of RET and H-RAS proto-oncogenes. Virchows Arch. 2012;461(5):531–40.CrossRef
39.
Gailey MP, Bayon R, Robinson RA. Cribriform adenocarcinoma of minor salivary gland: a report of two cases with an emphasis on cytology. Diagn Cytopathol. 2014;42(12):1085–90.CrossRef
40.
Worrall DM, Brant JA, Chai RL, Weinstein GS. Cribriform adenocarcinoma of the tongue and minor salivary gland: transoral robotic surgical resection. ORL. 2015;77(2):87–92.CrossRef
41.
Appukutty SJ, Di Palma S, Daborn L, Bagwan I, Beeslaar S. Cribriform adenocarcinoma of minor salivary glands. Diagn Histopathol. 2015;21(9):380–2.CrossRef
42.
Brierley D, Green D, Speight P. Cribriform adenocarcinoma of the minor salivary glands arising in the epiglottis—a previously undocumented occurrence. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(3):e174–6.CrossRef
43.
Madhura MG, Kumar BV, Suma S, Sarita Y. Cribriform adenocarcinoma of minor salivary gland: a mimic of polymorphous low-grade adenocarcinoma. J Oral Maxillofac Pathol. 2016;20(3):536–9.CrossRef
44.
Majewska H, Skalova A, Weinreb I, Stodulski D, Hyrcza M, Stankiewicz C, et al. Giant cribriform adenocarcinoma of the tongue showing PRKD3 rearrangement. Pol J Pathol. 2016;67(1):84–90.CrossRef
45.
Xu B, Aneja A, Ghossein R, Katabi N. Predictors of outcome in the phenotypic spectrum of polymorphous low-grade adenocarcinoma (PLGA) and cribriform adenocarcinoma of salivary gland (CASG): a retrospective study of 69 patients. Am J Surg Pathol. 2016;40(11):1526–37.CrossRef
46.
Mariano FV, Varanda RF, Schultz L, Correa MB, de Almeida OP, Altemani A, et al. Cribriform adenocarcinoma of the soft palate with multiple lymph node metastasis and long-term follow-up. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(4):e117–22.CrossRef
47.
Pagano A, Dennis K. Cribriform adenocarcinoma of the minor salivary gland arising in the tonsil with metastasis to a cervical lymph node: a case report with description of fine needle aspiration cytology. Diagn Cytopathol. 2017;45(5):468–71.CrossRef
48.
Michal M, Kacerovska D, Kazakov DV. Cribriform adenocarcinoma of the tongue and minor salivary glands: a review. Head Neck Pathol. 2013;7(Suppl 1):3–11.CrossRef
49.
Seethala RR, Stenman G. Update from the 4th edition of the world health organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55–67.CrossRef
50.
Seethala RR, Johnson JT, Barnes EL, Myers EN. Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience. Arch Otolaryngol Head Neck Surg. 2010;136(4):385–92.CrossRef
51.
Weinreb I, Zhang L, Tirunagari LM, Sung YS, Chen CL, Perez-Ordonez B, et al. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin. Genes Chromosom Cancer 2014;53(10):845–56.CrossRef
52.
Weinreb I, Piscuoglio S, Martelotto LG, Waggott D, Ng CK, Perez-Ordonez B, et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat Genet. 2014;46(11):1166–9.CrossRef
53.
Fonseca I, Assaad A, Katabi N, Seethala RR, Weinreb I, Wenig BM. Polymorphous adenocarcinoma. In: El-Naggar A, Chan JKC, Grandis J, Takata T, Slootweg PJ, editors. World health organization classification of tumours: pathology and genetics of head and neck tumours. 4th ed. Lyon: IARC Press; 2017. pp. 167–8.
54.
55.
Nam SJ, Roh J-L, Cho K-J, Choi S-H, Nam SY, Kim SY. Risk factors and survival associated with distant metastasis in patients with carcinoma of the salivary gland. Ann Surg Oncol. 2016;23(13):4376–83.CrossRef
56.
Huang AT, Tang C, Bell D, Yener M, Izquierdo L, Frank SJ, et al. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015;51(6):610–5.CrossRef
57.
Seethala RR, Bullock MJ, Carlson DL, Ferris RL, Harrison LB, McHugh JB, et al. Protocol for the examination of specimens from patients with carcinomas of the major salivary glands. Northfield, IL: College of American Pathologists; 2017.
58.
Patel TD, Vazquez A, Marchiano E, Park RC, Baredes S, Eloy JA. Polymorphous low-grade adenocarcinoma of the head and neck: a population-based study of 460 cases. Laryngoscope 2015;125(7):1644–9.CrossRef
59.
Kimple AJ, Austin GK, Shah RN, Welch CM, Funkhouser WK, Zanation AM, et al. Polymorphous low-grade adenocarcinoma: a case series and determination of recurrence. Laryngoscope 2014;124(12):2714–9.CrossRef
Metadata
Title
Historical Evolution of the Polymorphous Adenocarcinoma
Author
Juan C. Hernandez-Prera
Publication date
01-09-2019
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 3/2019
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-018-0964-9

Other articles of this Issue 3/2019

Head and Neck Pathology 3/2019 Go to the issue

Letter to the Editor

Who Originally Described Pindborg Tumor?

Original Paper

Seventeen New Cases of Chronic Ulcerative Stomatitis with Literature Review

Original Paper

Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases

Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 17, 2019, National Harbor, MD

Challenges in Minor Salivary Gland Biopsies: A Practical Approach to Problematic Histologic Patterns

Case Report

P53 Gene Mutation Identified by Next Generation Sequencing in Poorly Differentiated Neuroendocrine Carcinoma of the Nasal Cavity

Invited Review

Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms